VIRMA (KIAA1429), a regulator of the METTL3-METTL14 methyltransferase complex, is upregulated in acute-phase CML, contributing to elevated m6A levels [26]. Here, VIRMA is linked to chronic myelogenous leukemia, BCR-ABL1 positive.